Why INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarket - Absci (N

INVO Bioscience, Inc. (NASDAQ:INVO) shares surged in pre-market trading after the company posted a narrower loss for the third quarter.

INVO Bioscience posted quarterly loss of 70 cents per share, versus a year-ago loss of $4.19 per share. The company’s quarterly sales surged 314% year-over-year to $974,894.

INVO Bioscience shares climbed 31.1% to $2.11 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

Alaunos Therapeutics, Inc. (NASDAQ:TCRT) shares rose 62.9% to $0.1354 in pre-market trading after falling 12% on Monday.
reAlpha Tech Corp. (NASDAQ:AIRE) shares surged 57.8% to $9.30 in pre-market trading after jumping around 34% on Monday.
Hanryu Holdings, Inc. (NASDAQ:HRYU) shares rose 40.2% to $1.36 in pre-market trading after falling 3% on Monday.
Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) shares rose 24.3% to $2.66 in pre-market trading after the company announced process to explore strategic alternatives.
RedHill Biopharma Ltd. (NASDAQ:RDHL) rose 15.3% to $0.3574 in pre-market trading.
Absci Corporation (NASDAQ:ABSI) rose 14.4% to $1.43 in pre-market trading. Almirall and Absci disclosed AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases.
PaxMedica, Inc. (NASDAQ:PXMD) gained 12.3% to $1.92 in pre-market trading. The company recently announced research findings in the Annals of General Psychiatry regarding a study on low-dose suramin intravenous infusions as a potential treatment for Autism Spectrum Disorder.
Advent Technologies Holdings, Inc. (NASDAQ:ADN) shares rose 11.8% to $0.4848 in pre-market trading.
Singular Genomics Systems, Inc. (NASDAQ:OMIC) gained 11.4% to $0.39 in pre-market trading. Singular Genomics Systems is expected to report financial results for the third quarter 2023 after the closing bell on Nov. 14, 2023.

Losers

The Beauty Health Company (NASDAQ:SKIN) dipped 51.7% to $1.88 in pre-market trading after the company reported weaker-than-expected financial results for its third quarter and revised its net sales outlook. Also, the company suspended its long-term full-year 2025 forecast.
Harrow, Inc. (NASDAQ:HROW) shares fell 24.6% to $9.67 in pre-market trading as the company reported downbeat third-quarter financial results and lowered its revenue guidance.
Applied UV, Inc. (NASDAQ:AUVI) shares fell 22.6% to $0.2090 in pre-market trading after reporting selected preliminary financial results for the third quarter.
Akili, Inc. (NASDAQ:AKLI) shares fell 21.4% to $0.3531 in pre-market trading. The company recently posted a narrower-than-expected quarterly loss.
HeartCore Enterprises, Inc. (NASDAQ:HTCR) fell 16.3% to $0.4350 in pre-market. HeartCore recently posted downbeat third-quarter sales.
Peraso Inc. (NASDAQ:PRSO) shares fell 14.7% to $0.2038 in pre-market trading after the company announced third-quarter results.
Fisker Inc. (NYSE:FSR) shares fell 13.4% to $3.56 in pre-market trading following third-quarter results.
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) fell 13.1% to $0.1859 in pre-market trading after declining around 7% on Monday. TRACON Pharma recently posted a profit for the third quarter.
Tenax Therapeutics, Inc. (NASDAQ:TENX) fell 10.9% to $0.5527 in pre-market trading. Tenax Therapeutics shares jumped 297% on Monday morning after the company received FDA clearance of the IND for TNX-103, an oral levosimendan, to treat pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF).
Beyond Air, Inc. (NASDAQ:XAIR) shares fell 10.3% to $1.82 in pre-market trading following weak quarterly results.

Now Read This: Home Depot Likely To Report Lower Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

ABSIAbsci Corp

$5.133.54%

Overview

AIREReAlpha Tech Corp

$2.243.70%

AUVIAPPLIED UV INC by Applied UV, Inc.

$0.00040-%

HROWHarrow Inc

$32.515.33%

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.